Navigation Links
Study shows young adults want to recover from addiction but need help to make it happen
Date:9/30/2011

ost-treatment. Self-efficacy or increased confidence in ability to sustain recovery was the strongest predictor of abstinence.

Slaymaker of Hazelden adds, "The young people in our study were quite motivated to do well in treatment but lacked the confidence, coping skills, and commitment to AA that are critical to longer-term success. Treatment appears to work by increasing their confidence and ability to make and sustain healthy, recovery-related efforts."

The findings suggest residential treatment provides the boost that the young people need. By reducing their psychological distress, developing their recovery-focused coping skills, increasing their commitment to AA and other groups, and by enhancing their overall confidence to stay clean and sober, young people make meaningful changes in treatment that position them for improved outcomes. Because self-efficacy was a strong predictor of abstinence, it may serve as a useful clinical summary indicator to monitor change and relapse potential among young adults in treatment.


'/>"/>

Contact: Christine Anderson
canderson@hazelden.org
651-213-4231
Hazelden
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Early to bed and early to rise -- study suggests its keeping kids leaner
2. No One Treatment for Acid Reflux Clearly Better Than Another: Study
3. Otherwise Healthy Older Men Undertreated for Prostate Cancer: Study
4. Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
5. Computational modeling can help plan vaccine introduction, Pitt study finds
6. Magic Mushroom Compound Triggered Positive Personality Change in Study
7. Weeds are vital to the existence of farmland species, study finds
8. Oral steroids linked to severe vitamin D deficiency in nationwide study
9. Cheap Drug Helps Smokers Quit, Study Finds
10. Study finds consumers may have more control over health costs than previously thought
11. Easily embarrassed? Study finds people will trust you more
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... its popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection ... VitaSkin™ pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It is ... alliance is dedicated to the provision of quality addiction treatment and the ...
(Date:9/1/2015)... California (PRWEB) , ... September 01, 2015 , ... ... Arrowsmith interviewed dating men and pick-up artists about their experiences of female beauty, ... men’s bodily concerns, including penis issues, as well as their relationships with other ...
(Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has them. Whether ... make things easier for parents, caregivers and children too. Here are three reasons why ... and small become more fluid. When a routine is implemented into a child’s schedule, ...
(Date:9/1/2015)... ... ... September is Baby Safety Month, and Lightning Labels wants to ... ones' safety top of mind at all times. , Sponsored by the Juvenile Products ... JPMA's Baby Safety Zone website, this year's theme is A Room with A Safe ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3
... STANFORD, Calif. Researchers at the Stanford University School ... three-dimensional cancers in a tissue culture dish for the ... divide and invade surrounding tissue will help physicians better ... new technique also provides a way to quickly and ...
... ,Kidney Donations by the Poor Are on the Decline ... incomes are more likely to develop kidney failure and less ... of other socioeconomic classes. Because fewer individuals in the U.S. ... of British Columbia, in Vancouver, Canada) and colleagues examined trends ...
... HealthDay Reporter , FRIDAY, Nov. 19 (HealthDay News) ... relax and have a drink a two, but they also ... studies show. The researchers found that fears about moderate ... about weight are not. Both studies, conducted by different ...
... November 19, 2010 - Data presented today from a ... recurrent glioblastoma tumors suggest that Tumor Treating Fields (TTF) ... of life scores compared to best standard of care ... of Neurosurgery at Tel-Aviv Sourasky Medical Center, presented the ...
... pinworm medicine is a new lead in the search for ... The findings, reported by Vanderbilt University Medical Center researchers in ... a fresh approach for developing therapeutics that target the pathway. ... the second deadliest type of cancer in the developed world ...
... construct an online interactive world map which gives stark facts ... and following the birth of their child. Social scientists ... collaboration with the White Ribbon Alliance for Safe Motherhood and ... excess of 160,000 called ,The Atlas of Birth, which also ...
Cached Medicine News:Health News:Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes 2Health News:Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes 3Health News:Efforts needed to address disparities in kidney transplantation 2Health News:Efforts needed to address disparities in kidney transplantation 3Health News:Efforts needed to address disparities in kidney transplantation 4Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 2Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 3Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 4Health News:Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting 2Health News:Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting 3Health News:New path for colon cancer drug discovery 2Health News:Online map of maternal health to inform world leaders 2
(Date:8/31/2015)... , Aug. 31, 2015 With ... cytometry is experiencing a rise in active partnerships. ... in underdeveloped nations to quantitate CD4 cell markers ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... the Global Flow Cytometry Market ( http://www.frost.com/nf0e ), ...
(Date:8/31/2015)...  The departments of Drug and Alcohol Programs (DDAP) ... 90 to raise awareness for International Overdose Awareness Day ... Pennsylvania and help more Pennsylvanians with substance ... the Building Bridges to Recovery initiative. ... to a disease that is fully treatable, if given ...
(Date:8/31/2015)... Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest independent ... & CEO, and Sean Whelan , CFO, will present ... and Mr. Whelan are scheduled to participate in the Wells ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... participate in the Robert W. Baird 2015 Healthcare Conference in ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... LOS ANGELES--(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. ... Phase,II data on the Company's prostate cancer drug ... Urological,Association (AUA) Annual Meeting, which is currently taking ... Dr. Timothy A.,Yap from the Cancer Research UK ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11